Psoriatic arthritis
3 years 1 month ago
This post hoc analysis of SPIRIT 1&2 in #psoriaticarthritis pts w/ symptoms indicative of axial involvement showed that Ixekizumab reduced axial symptoms and improved QoL at wks 16 & 24.
Reassuring data.
@RheumNow #ACR21 abs1347 https://t.co/aFixZdiEyx
3 years 1 month ago
Risankizumab for Active Psoriatic Arthritis with Dr. Robert Chao ( @doctorRBC )
#ACR21
https://t.co/0zskkywWu1 https://t.co/n3qs19rQNG
3 years 1 month ago
Interesting results where cannabidiol NEG results in RCT in hand OA and PsA. ? Throw out the ‘pot’with the dish water? Did it stimulate appetites? Was pain the same but interference less? Abst#1456 #ACR21 @RheumNow https://t.co/rnz82Paxkr
Highlight reports from Sunday, Day 2 at ACR Convergence included:
VITAL Trial: Vitamin D and n-3 Fatty Acid Supplements Protect Against Autoimmune Disease
Abstract 0957 – Dr. Karen…
Psoriatic arthritis (PsA) commonly affects peripheral joints. In up to a quarter of PsA patients, the spine may be involved and this is known as psoriatic spondylitis (PsSpA). An important research…
3 years 1 month ago
CBD for pain in hand OA/inactive PsA:
- works in animal models (many things do)
- other neg RCTs didn't use CBD itself
- DBRCT: 12w continuous, n=136, min dropout
Result:
does absolutely nothing
I bet big money it will be tried again & again
@Joner_MD #ACR21 ABST1456 @RheumNow https://t.co/lZLVrgrKST
3 years 1 month ago
Among 6 CV risk algorithms, the best to predict the carotid plaque (CP) in PsA is the ACC/AHA risk score showed an AUC 0.681 (0.551-0.812), p=0.008, a cut-off point ≥4.8, sensitivity of 63.6%, and specificity of 64.4%
⭐️Prevalence CP 42.3%
Abst #1315 #ACR21 @RheumNow https://t.co/hRvyjetYq3
Poster Hall